# Validation of a Urine Assay to Measure Tenofovir Levels in Patients Taking Tenofovir Alafenamide

> **NCT03350672** · PHASE4 · COMPLETED · sponsor: **Philadelphia Fight** · enrollment: 37 (actual)

## Conditions studied

- Hiv

## Interventions

- **DRUG:** FTC/TAF

## Key facts

- **NCT ID:** NCT03350672
- **Lead sponsor:** Philadelphia Fight
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-16
- **Primary completion:** 2018-03-29
- **Final completion:** 2018-05-01
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2021-09-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03350672

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03350672, "Validation of a Urine Assay to Measure Tenofovir Levels in Patients Taking Tenofovir Alafenamide". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03350672. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*